Johnson & Johnson Receives CE Marking For ACUVUE OASYS MAX 2-Week, New Reusable Contact Lens Featuring Proprietary MAX Technologies To Deliver Lasting Comfort And Clear Vision, Even At Day 14
Key takeaways
- JNJ’s new 2‑week reusable lens clears European regulators, positioning it to capture a larger share of the growing reusable‑lens market.
- 140 million contact‑lens wearers worldwide
- half choose reusable lenses
- CE Marking achieved
What happened
Johnson & Johnson (NYSE: JNJ) received CE Marking for its new ACUVUE OASYS MAX 2‑Week reusable contact lens, a product that uses proprietary MAX technologies to offer lasting comfort and clear vision up to day 14.
Why it matters
The CE approval allows the lens to be sold in European markets, expanding JNJ’s contact‑lens portfolio and tapping a growing segment of users who prefer reusable lenses and demand high comfort for screen‑heavy lifestyles.
Short-term and longer-term
Short-term. Short‑term traders should watch for European sales data and any pricing adjustments once the lens hits the market.
Longer-term. From a longer‑term view, the CE approval expands JNJ’s product pipeline in a high‑growth segment of the contact‑lens market.